The late-breaking results will highlight who may benefit from these therapies, adults living with overweight or obesity, including those with type 2 diabetes (T2D), what the data show on efficacy, safety, and tolerability, when and where the findings will be presented during the ADA meeting, and why they are important for advancing long-term weight management and treatment adherence
Lou H, Li H, Zhang S, Lu H, Chen Q (2021) A review on preparation of betulinic acid and its biological activities
Stute, P., Wildt, L., & Neulen, J
Curbs Sweet Cravings: Say goodbye to unhealthy snacks
- The same study found that adults under 40, who are less likely to be on these medications, still carry the full cardiovascular risk of obesity
10.1128/CMR.00338-20 39 TangW